CSIMarket Company Name, Ticker, Industry, else..
 

Neurometrix Inc   (NASDAQ: NURO)

Neurometrix Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

NURO Sales vs. its Competitors Q4 2024


Comparing the current results to its competitors, Neurometrix Inc reported Revenue decrease in the 4 quarter 2024 year on year by -36.86 %, despite the revenue increase by the most of its competitors of 8.64 %, recorded in the same quarter.

• List of NURO Competitors





Revenue Growth Comparisons




Net Income Comparison

Neurometrix Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 153.47 %

<<  NURO Stock Performance Comparisons


Neurometrix Inc 's Comment on Competition and Industry Peers


The company faces competition from entities that may independently develop similar technologies. Its success depends in part on avoiding infringement of patents held by competitors and potential competitors. Patent infringement litigation could limit or prevent the company's ability to develop, manufacture, and sell products. The company may need to obtain licenses for patents or proprietary rights from others to continue commercialization; however, such licenses may not be available or may be non-exclusive, permitting competitors to access the same intellectual property. Failure to protect intellectual property rights could result in loss of market share to competitors.



  

Overall company Market Share Q4 2024
Overall company, revenue fell by -36.86 % and company lost market share, to approximately 0 %.




<<  More on NURO Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Neurometrix Inc




Axonics Inc
Share Performance



+0.80%
Over The Past 5 Days
Axonics Inc
Profile

Axonics Inc is a medical technology company that focuses on the development and commercialization of solutions for treating bladder and bowel dysfunction. Their business model revolves around the manufacturing and sales of implantable neuromodulation devices that help patients suffering from these conditions. They aim to provide innovative and effective solutions that enhance patients' quality of life while maintaining partnerships with healthcare professionals and expanding their market reach.

More about Axonics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,626.231 mill. $ 430.953 mill. $ -5.660 mill.


Bimi International Medical Inc
Share Performance



0.00%
Over The Past 5 Days
Bimi International Medical Inc
Profile

Bimi International Medical Inc is a healthcare company that operates on a business model focused on providing medical products and services internationally. They aim to leverage their expertise in medical technologies to offer innovative and cost-effective solutions that cater to the global healthcare industry.

More about Bimi International Medical Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.001 mill. $ 18.089 mill. $ -22.658 mill.


Clearpoint Neuro Inc
Share Performance



+5.35%
This Year
Clearpoint Neuro Inc
Profile

Clearpoint Neuro Inc's business model revolves around providing advanced deep brain stimulation (DBS) solutions for the treatment of neurological disorders. It focuses on developing and commercializing innovative medical devices, software, and services that enable precise and accurate targeting for electrode placement during neurosurgical procedures.

More about Clearpoint Neuro Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 436.703 mill. $ 40.614 mill. $ -29.066 mill.


Electrocore Inc
Share Performance



+79.28%
One Year
Electrocore Inc
Profile

Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.

More about Electrocore Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 84.427 mill. $ 34.458 mill. $ -15.382 mill.


Inspire Medical Systems inc
Share Performance



+0.32%
Over The Past 5 Days
Inspire Medical Systems inc
Profile

Inspire Medical Systems Inc operates on a direct-to-patient business model, focused on developing and commercializing innovative medical devices for patients suffering from sleep apnea. The company's business model revolves around providing a unique therapy solution through the development of its proprietary Inspire therapy system, which includes a surgically implanted device that stimulates the upper airway during sleep. By targeting both physicians and patients, Inspire Medical Systems aims to improve clinical outcomes and bring relief to those with unmet needs in the field of sleep apnea treatment.

More about Inspire Medical Systems inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,758.338 mill. $ 915.060 mill. $ 131.136 mill.

12 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Neurometrix Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Neurometrix Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.